Get a Health Optimisation Plan That Can Do Both: HRT and GLP-1s

For decades, women in perimenopause and menopause have been told that weight gain is inevitable. Hormone replacement therapy (HRT) helped improve hot flashes, sleep, and mood, but the scale often didn’t move. Meanwhile, GLP-1 receptor agonists, like semaglutide and tirzepatide, have made headlines for their powerful weight-loss results.

A growing body of research, including a 2024 study, suggests something important: when used together, HRT and GLP-1s may create greater weight loss benefits than either therapy alone.

This is where medical synergy comes in.

What Is HRT?

Hormone replacement therapy (HRT) helps replace hormones such as oestrogen and progesterone that decline during menopause. Testosterone may also be considered in certain circumstances.

In women, HRT may:

• Improve sleep, mood and brain clarity
• Reduce hot flushes and night sweats
• Support bone density and muscle preservation
• Improve vaginal and sexual health
• Enhance overall quality of life

But when it comes to weight loss, HRT has limitations. While managing hormonal changes may support overall health and wellbeing, HRT is not a weight-loss treatment and does not typically result in significant fat loss on its own.

What Are GLP-1 Medications?

GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), mimic the effects of hormones naturally produced in the body.

They can work by:

• Reducing appetite and cravings
• Slowing gastric emptying to increase feelings of fullness
• Improving blood glucose control
• Supporting weight management

These effects make GLP-1 medications an important tool for some people managing overweight, obesity and metabolic health.

Why Combining HRT and GLP-1s May Help

A 2024 study highlighted an interesting potential connection between menopausal hormone therapy and GLP-1 treatment.

The study found that postmenopausal women using semaglutide alongside hormone therapy experienced greater average weight loss than those using semaglutide without hormone therapy.

However, it's important to understand that this was a small, retrospective observational study. It does not prove that HRT directly caused the additional weight loss, and larger studies are needed to better understand the relationship.

So, why might this combination be relevant?

• HRT addresses menopausal hormone changes: Changes in oestrogen during menopause can affect body composition, metabolic health and where the body stores fat.
• GLP-1s support appetite and metabolic health: They can help regulate appetite, increase feelings of fullness and support blood glucose control.
• Together, they may provide a more comprehensive approach: For some women, addressing menopausal symptoms and weight management at the same time may be appropriate.

Think of it as considering both the hormonal and metabolic aspects of health rather than looking at weight in isolation.

Real-World Benefits for Women in Midlife

When these therapies are appropriate and used under medical supervision, potential benefits may include:

• Improved weight management
• Better management of menopausal symptoms
• Support for metabolic health
• Improved quality of life
• A more personalised approach to managing changes during midlife

It's important to remember that results vary between individuals, and not every woman will need or benefit from both treatments.

Is It Right for You?

Not every woman is a candidate for HRT or GLP-1 therapy, and appropriate assessment and ongoing medical monitoring are essential.

For some women in perimenopause or menopause, considering both hormonal health and metabolic health may form part of a comprehensive approach to their care.

If you've felt frustrated by changes in your weight, slow progress with weight-management strategies or symptoms associated with hormonal changes, this may be a conversation worth having with a healthcare provider who understands both menopause and metabolic health.

You Deserve More Than One Tool

The future of women's health isn't necessarily about choosing between hormone therapy and modern weight-management treatments.

It's about understanding what your individual body needs.

For some women, HRT may be appropriate. For others, medical weight management may have a role. And for some, both may form part of a broader treatment plan.

HRT can help manage symptoms associated with menopause, while GLP-1 medications can support weight management and metabolic health where clinically appropriate.

Together, they may offer another way to approach perimenopause, menopause, weight management and long-term metabolic health.

The most important thing is that your treatment plan is based on your individual health, goals and circumstances, rather than a one-size-fits-all approach. Book a consultation!